To evaluate the predictive ability of the PET/CT CCR2 radiotracer, we conducted a prospective assessment tracking all-cause mortality, AAA-related events (ruptures, surgical repairs, and post-EVAR endoleaks), and mean AAA growth (Table S3). Here, CCR2 is linked to triple-A syndrome.